SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lipocine, Inc. (LPCN) and Lead Plaintiff Deadline August 30, 2016

NEW YORK, July 7, 2016 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company") (NASDAQ: LPCN) and certain of its officers.   The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period").

The Complaint alleges that throughout the Class Period defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Lipocine's filing of its New Drug Application to the U.S. Food and Drug Administration for LPCN 1021, Lipocine's lead product candidate, contained deficiencies; and (2) consequentially, defendants' statements about Lipocine's business and operations were false and misleading and/or lacked a reasonable basis.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: http://www.bgandg.com/#!lpcn/geg3g or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.  If you suffered a loss in Lipocine you have until August 30, 2016 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert---bronstein-gewirtz--grossman-llc-reminds-investors-of-class-action-against-lipocine-inc-lpcn-and-lead-plaintiff-deadline-august-30-2016-300294968.html

SOURCE Bronstein, Gewirtz & Grossman, LLC